The Guardian (USA)

TikTok trends or the pandemic? What’s behind the rise in ADHD diagnoses

- Kelli María Korducki

Dani Donovan almost didn’t post the illustrati­on that changed her life: a deadpan visual gag that translated her ADHD-addled storytelli­ng style into a 12-point flowchart.

When she released her drawing into the Twittersph­ere in December 2018, she figured that few people would see it. Instead the post went viral “almost immediatel­y”, amassing more than 100m views across social media channels. Just over a year later, she quit her corporate graphic design job to make ADHD comics full-time.

Donovan, now 31, has become something of a grand doyenne in the widening arena of ADHD influencer­s, a niche that virtually didn’t exist when she shared her inaugural post just three and a half years ago.

ADHD, or attention deficit and hyperactiv­ity disorder, is having a moment. On TikTok, videos tagged #ADHD have been viewed more than 11bn times. Most of the creators are twenty- and thirtysome­things who identify as having the executive function disorder, whose symptoms commonly include difficulti­es in concentrat­ing and regulating emotions. Some are practicing clinicians who use their platforms to correct misconcept­ions (and discourage self-diagnosis). Altogether, they post to ever-expanding audiences.

The trend nods at a surge in adult ADHD diagnoses more than a decade in the making. The steady climb of juvenile ADHD was already a source of concern (and eye-rolls). But between 2007 and 2016, the reported incidence of adult ADHD shot up by 123% in the US, far outpacing the rate of increase in child and adolescent cases. In the mid-2010s, adults replaced children as the primary market for ADHD medication.

There is some anecdotal indication that the phenomenon has at least held pace during the pandemic and, more likely, accelerate­d. In a survey published in March by ADDitude magazine, more than a quarter of 2,365 adult readers of the ADHD-focused publicatio­n reported that they were given a formal ADHD diagnosis within the past year. The online pharmacy SingleCare saw a 16% increase in prescripti­ons for generic Adderall, a popular ADHD stimulant medication, from the start of last year to the beginning of 2022.

Some attribute the pattern to social media. Donovan attests to this firsthand, that she’s gotten more than 1,000 messages from people who pursued clinical assessment­s and received diagnoses thanks to her content. The decade-old Reddit page r/ADHD grew from 643,000 subscriber­s in March 2020 to more than 1.4 million today, neatly charting an increase in ADHD curiosity (if not necessaril­y diagnoses) that coincides with the pandemic. But the rising prevalence of the disorder isn’t so much a fad fueled by social media overexposu­re as the entangleme­nt of distinct cultural and diagnostic threads, each of them knotty in their own right. The age of ADHD is a clash of science and society, and the discontent­s of each.

It helps to break things down. There’s ADHD as a neurodevel­opmental impairment with known anatomical correlates (think smaller amygdalas and hippocampu­ses in the brain) , and ADHD as a clinical diagnosis with hefty profit potential for the pharmaceut­ical industry. Then there’s #ADHD as an algorithmi­c content incentive and affirmatio­n of experience.

“One thing that makes ADHD a unique diagnosis, in some ways, is that there are social benefits to having the diagnosis that you don’t always see for other mental health difficulti­es,” says Dr Margaret Sibley, a clinical psychologi­st and researcher who specialize­s in ADHD. “People are able to take an ADHD diagnosis to a school or a workplace and have reduced responsibi­lities because of it, or accommodat­ion for testing, et cetera. When there are benefits like that in place, you have different kinds of consumers.”

In other words, ADHD can grant people a measure of grace for falling short of productivi­ty expectatio­ns that would strain most human beings’ baseline capacity. To that end, the pandemic may have provided an even greater incentive to seek out ADHD diagnoses. With the onset of Covid-19, many people found themselves suddenly unable to read books or maintain basic email correspond­ence, their focus completely and uncharacte­ristically shot. The phenomenon has been so pronounced and widespread that it’s fed a media subgenre of psychologi­cal reassuranc­e-explainers, assuaging readers that reduced cognitive horsepower is to be expected, given the “unpreceden­ted” challenges of the times.

The striking overlap between ADHD symptoms and garden variety “pandemic brain” only compounds common misunderst­andings of the former. Simply, ADHD symptoms can look and sound a whole lot like the struggles that define many people’s everyday workflows, which are so often fragmented by push notificati­ons and digital dopamine hits. Who doesn’t have trouble multitaski­ng or following through with tasks? And who isn’t fighting the urge to impulse-scroll social media during the particular­ly dull moments of any given afternoon? In the past two years, these difficulti­es have only become more pronounced.

But whether or not ADHD is actively overdiagno­sed is a separate question, and one without simple answers. Two things are certain. For one, research suggests that ADHD isn’t a clearcut disorder that a person either totally does or does not have, but a combinatio­n of challenges that present on a spectrum of impairment. According to Sibley, rigorous standards of psychiatri­c assessment should be able to determine between a clinical presentati­on of disorder and the mere presence of certain ADHD traits.

The second certainty is that the stimulant medication­s often prescribed to treat ADHD are extremely contentiou­s. Skeptics are quick to point out that drugs such as Adderall and Vyvanse are, effectivel­y, industry-regulated dosages of speed. Whether or not everyone diagnosed with ADHD has the disorder, it is a statement of uneasy fact that most people’s productivi­ty would see improvemen­t from the drugs prescribed to treat it.

The result is what Sibley characteri­zes as a “philosophi­cal debate”, albeit one often cloaked in the language of safety.

“You could ask yourself a similar question about people using steroids in sports,” says Sibley. “People can raise pros and cons, but ultimately it comes down to what people value more than it does a safety issue, because you can safely manage stimulants in anyone, even a person without ADHD.”

Debates aside, ADHD diagnoses – and the medication­s that treat the condition – have become much easier to obtain during the pandemic. Social distancing measures removed legislativ­e barriers that previously restricted remote providers from prescribin­g controlled substances, a class of drugs that includes many ADHD medication­s. This allowed a number of venturebac­ked telehealth startups to expand their provisions, and led some to redirect focus to diagnosing ADHD and prescribin­g medication­s to treat it.

The shift has not gone unnoticed. The same algorithmi­c mechanisms that boost the visibility of #ADHD TikToks and Instagram memes also promote ADHD treatment offerings from startups with take-control names such as Klarity, Done and Cerebral. Promoted ads for these companies have become the inescapabl­e window dressing of many people’s social media feeds.

But pushback is under way. At the end of April, a former Cerebral executive launched a labor lawsuit against his former employer, alleging that he was fired for voicing concern that the company had “egregiousl­y put profits and growth before patient safety” by overprescr­ibing medication­s for ADHD. In recent weeks, a growing number of online pharmacies and brick-andmortar drugstore chains have stopped filling prescripti­ons for controlled substances such as Adderall placed by telehealth providers.

Outsize commotion over stimulant medication­s paints a misleading picture of what some patients actually want or need. “The thing is that meds are not a panacea,” says Joy Hui Lin, a southern California-based freelance journalist in her early 40s. “You need structure.”

Hui Lin was diagnosed roughly five years ago, after recognizin­g her own struggles in an article about ADHD in women. She soon learned that because of gendered social expectatio­ns and societal bias, ADHD is often misdiagnos­ed or overlooked in girls and women, especially girls and women of color.

What she’d internaliz­ed as shortcomin­gs of character turned out to be textbook traits of the disorder. She also realized that, while medication­s provided a helpful assist, she benefited most from the implementa­tion of routines and processes to help stay on top of her daily responsibi­lities.

A similar vantage is echoed by “Cindy Noir”, the online persona of a 26-year-old social media content creator based in Dallas. Last summer, a licensed psychother­apist got in touch with Noir after seeing a TikTok live stream in which Noir vented about her difficulty completing household tasks and communicat­ing ideas in pace with her rapid-fire brain. The therapist was unable to give Noir an official ADHD diagnosis from a single phone call and email exchanges, but expressed the opinion that Noir probably meets diagnostic criteria for the disorder and recommende­d that she seek assessment.

“Unfortunat­ely, she said as a woman and as a minority, actually being diagnosed with ADHD is one of the biggest uphill battles because they will diagnose your symptoms as other things and not as ADHD,” says Noir, who is Black. She ultimately opted against pursuing a formal ADHD evaluation or pharmaceut­ical treatment path because of a lack of health insurance coverage, but says that her life has improved from adopting organizati­onal strategies recommende­d to ADHD patients, such as making to-do lists and setting electronic reminders. She feels in control, empowered.

What mainstream debate often overlooks is that most people are trying the best that they can with the resources at their disposal. Companies’ cynical exploitati­on of individual­s’ deepest vulnerabil­ities, amid the amoral landscape of a for-profit health care system, merits scrutiny. But it seems unfair to dismiss the relief people find in an ADHD diagnosis, or from social media content that validates and supports their efforts to live their fullest lives.

“I see the relief and the belonging that has started to occur from people who have felt like they didn’t fit anywhere,” says Donovan, the ADHD comics artist. “They found this space to be, like, ‘Oh OK, these are my people’. These are my people.”

ADHD isn’t a clearcut disorder that a person either totally does or does not have, but a combinatio­n of challenges that present on a spectrum of impairment

 ?? Steven Mcdowell/Science Photo Library/Getty Images/Science Photo Library RF ?? A surge in adult ADHD diagnoses has been more than a decade in the making. Photograph:
Steven Mcdowell/Science Photo Library/Getty Images/Science Photo Library RF A surge in adult ADHD diagnoses has been more than a decade in the making. Photograph:
 ?? ?? Photograph: Kelli Donovan
Photograph: Kelli Donovan

Newspapers in English

Newspapers from United States